The 8-k basically outlined what will happen in the

The 8-k basically outlined what will happen in the very short term (8-10 weeks). Quite frankly, I hope GC makes his bonus. I am also impressed that he deferred the signing bonus. I don't think any of the naysayers have mentioned that little nugget of information. The FDA milestones are a smaller percentage of the bonus because the FDA always brings uncertainty. However, I think all of the bonus milestones are in there because they know they will be achieved. There have also got to be other milestones in the mix. GC has mentioned potential business development activities with MANF, spin out of the diagnostic division, and talk on here about build out of ICON relationship. Speaking of ICON. Regardless if it is a MSA, it is technically a partnership. Like it or not, that is a fact. Now that the data is known, that relationship can grow. There could be a JV Partner circling to bring it through FDA approval, but for RUO and CLIA, I believe ICON is plenty good.

One more thing. The great thing about investing is that you are free to sell your shares if you don't like what the company is doing. It's clear there are a couple/few who didn't like the news on Friday. I thought it was awesome. If you don't like it then sell. Very simple. We get the message though. We don't need message after redundant message.